Table 4. Triglyceride concentrations before and after Clinofibrate medication.
| Pre-dosage lipid value (mg/dl) |
Post-dosage lipid value (mg/dl) |
Difference (mg/dl) (Wilcoxon signed-rank test) |
||
|---|---|---|---|---|
| Triglyceride | Total | Median 355.20 | Median 161.85 | Median 125.15 |
| Mean 554.05 | Mean 308.44 | V=40,703, P=1.06 × 10−28 | ||
| Range 79.89–6,011.71 | Range 22.53–4,356.71 | |||
| CM | Median 36.61 | Median 8.82 | Median 18.25 | |
| Mean 94.21 | Mean 45.53 | V=38,077, P=4.53 × 10−21 | ||
| Range 0.61–2,327.52 | Range 0.19–1,137.74 | |||
| VLDL | Median 266.04 | Median 124.87 | Median 102.39 | |
| Mean 412.41 | Mean 230.68 | V=40,897, P=2.59 × 10−29 | ||
| Range 67.55–4,457.40 | Range 4.84–3,539.90 | |||
| LDL | Median 20.36 | Median 17.61 | Median 2.91 | |
| Mean 32.59 | Mean 23.33 | V=31,208, P=6.17 × 10−7 | ||
| Range 4.07–333.07 | Range 3.13–237.98 | |||
| HDL | Median 10.63 | Median 5.47 | Median 3.49 | |
| Mean 15.56 | Mean 8.86 | V=39,715, P=1.10 × 10−25 | ||
| Range 2.30–178.34 | Range 0.98–92.06 | |||
CM, Chylomicrons triglyceride concentration; VLDL, Very low density lipoprotein triglyceride concentration; LDL, Low density lipoprotein triglyceride concentration; HDL, High density triglyceride lipoprotein triglyceride concentration.